This review aims at evaluating whether or not there are data supporting a tailored use of standard taxanes i.e. docetaxel and paclitaxel in elderly patients with the aim to increase their therapeutic index.

Taxanes in the elderly: Can we gain as much and be less toxic? / Biganzoli L; Licitra S; Moretti E; Pestrin M; Zafarana E; Di Leo A. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - ELETTRONICO. - (2009), pp. 262-271.

Taxanes in the elderly: Can we gain as much and be less toxic?

MORETTI, ERICA;PESTRIN, MARTA;
2009

Abstract

This review aims at evaluating whether or not there are data supporting a tailored use of standard taxanes i.e. docetaxel and paclitaxel in elderly patients with the aim to increase their therapeutic index.
2009
262
271
Biganzoli L; Licitra S; Moretti E; Pestrin M; Zafarana E; Di Leo A
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/957858
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact